Correlation Between Vyne Therapeutics and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on Vyne Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Akari Therapeutics.
Diversification Opportunities for Vyne Therapeutics and Akari Therapeutics
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vyne and Akari is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Vyne Therapeutics and Akari Therapeutics
Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 0.49 times more return on investment than Akari Therapeutics. However, Vyne Therapeutics is 2.06 times less risky than Akari Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.21 per unit of risk. If you would invest 269.00 in Vyne Therapeutics on August 25, 2024 and sell it today you would earn a total of 34.00 from holding Vyne Therapeutics or generate 12.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vyne Therapeutics vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Vyne Therapeutics |
| Akari Therapeutics PLC |
Vyne Therapeutics and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vyne Therapeutics and Akari Therapeutics
The main advantage of trading using opposite Vyne Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Vyne Therapeutics vs. Akari Therapeutics PLC | Vyne Therapeutics vs. Salarius Pharmaceuticals | Vyne Therapeutics vs. Histogen | Vyne Therapeutics vs. SAB Biotherapeutics |
| Akari Therapeutics vs. Lyra Therapeutics | Akari Therapeutics vs. Hookipa Pharma | Akari Therapeutics vs. SAB Biotherapeutics | Akari Therapeutics vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |